NEW YORK, NY -- The Mark Foundation for Cancer Research has selected fourteen outstanding scientific research projects for ASPIRE Awards. Designed to answer key proof-of-concept questions in a short timeframe, the ASPIRE ( A ccelerating S cientific P latforms and I nnovative R esearch) program funds high risk, high reward approaches to solving complex problems in cancer research that tend to fall outside the scope of other funding opportunities.
The diverse group of scientists leading these ASPIRE projects represents disciplines across the spectrum of cancer research at top academic institutions throughout the United States and internationally. The projects address a wide range of topics in basic, translational, and clinical research including early cancer detection, novel combinations for immunotherapy, model systems to elucidate the mechanisms of tumorigenesis and metastasis, and chemical biology platforms to explore new therapeutic targets and pathways.
"These fourteen projects have the potential to truly advance the field of cancer medicine," said Michele Cleary, PhD, Chief Executive Officer of The Mark Foundation. "Each awardee proposed an innovative and bold idea that fully exemplified our vision for the ASPIRE program. We are delighted to welcome them into our growing family of funded investigators."
The Mark Foundation's new class of ASPIRE Awards are:
For additional information about The Mark Foundation's ASPIRE Awards, visit https://themarkfoundation.org/awardees/project-awards/ .
###
About The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research is dedicated to accelerating cures for cancer by integrating discoveries in biology with innovative technology. Launched in 2017, The Mark Foundation pursues its mission by funding a global portfolio of groundbreaking research carried out by individual investigators, multi-investigator teams, and inter-institutional collaborations.
Recognizing the obstacles that can prevent scientific advances from improving patient outcomes, The Mark Foundation maintains a nimble, high-impact approach to funding research that encompasses grants for basic and translational cancer research, as well as venture philanthropy investment in companies that bridge the gap between the bench and the bedside.
To learn more about the work of The Mark Foundation for Cancer Research, visit: https://themarkfoundation.org/